Public-private partnerships can be instrumental in mitigating economic disparities. By combining the resources of private biotech firms with the regulatory and distribution networks of governments, these partnerships can facilitate the development and dissemination of affordable and accessible biotech solutions. Such collaborations can also focus on capacity building in developing nations, ensuring that they have the infrastructure and knowledge to utilize new technologies effectively.